Taysha Gene Therapies Announces Annual Stockholder Meeting
The Annual Stockholder Meeting on Friday, June 17, 2022 at 10 am ET...
Source: globenewswire.com
Page 16 - Gene Therapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gene Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gene Therapy Program Today - Breaking & Trending Today
Passage Bio, Inc.'s (PASG) CEO Bruce Goldsmith on Q1 2022 Results - Earnings Call Transcript
Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Stuart Henderson - Vice President of Corporate Development and Investor...
Source: seekingalpha.com
Aruvant Announces Oral Presentation at American Society of Gene and Cell Therapy (ASGCT)
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that data demonstrating the...
Source: prnewswire.com
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Soci
- Accepted abstracts to be presented as oral presentations and posters highlight preclinical development progress for ARCUS® gene editing therapiesDURHAM, N.C.--(BUSINESS WIRE)--$DTIL #ARCUS--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic...
Source: pharmiweb.com
Gamida Cell (NASDAQ:GMDA) and Passage Bio (NASDAQ:PASG) Head to Head Analysis
Gamida Cell (NASDAQ:GMDA – Get Rating) and Passage Bio (NASDAQ:PASG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]
Source: etfdailynews.com